BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1384671)

  • 1. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.
    Giovannini M; Robanus-Maandag E; van der Valk M; Niwa-Kawakita M; Abramowski V; Goutebroze L; Woodruff JM; Berns A; Thomas G
    Genes Dev; 2000 Jul; 14(13):1617-30. PubMed ID: 10887156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.
    Williams EA; Ravindranathan A; Gupta R; Stevers NO; Suwala AK; Hong C; Kim S; Yuan JB; Wu J; Barreto J; Lucas CG; Chan E; Pekmezci M; LeBoit PE; Mully T; Perry A; Bollen A; Van Ziffle J; Devine WP; Reddy AT; Gupta N; Basnet KM; Macaulay RJB; Malafronte P; Lee H; Yong WH; Williams KJ; Juratli TA; Mata DA; Huang RSP; Hiemenz MC; Pavlick DC; Frampton GM; Janovitz T; Ross JS; Chang SM; Berger MS; Jacques L; Song JS; Costello JF; Solomon DA
    Neuro Oncol; 2023 Dec; 25(12):2221-2236. PubMed ID: 37436963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling schwannomas.
    Flucke UE; Hiemcke-Jiwa LS; Wesseling P
    Neuro Oncol; 2023 Dec; 25(12):2237-2238. PubMed ID: 37715980
    [No Abstract]   [Full Text] [Related]  

  • 4. Expert Commentary on Rare (Nonvestibular, Nontrigenimal) Cranial Nerve Schwannomas.
    Alemdar M
    J Neurosci Rural Pract; 2018; 9(2):175-176. PubMed ID: 29725164
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series.
    Stenman A; Falhammar H; Zedenius J; Juhlin CC
    Endocrine; 2023 Dec; 82(3):631-637. PubMed ID: 37535242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization.
    Begnami MD; Palau M; Rushing EJ; Santi M; Quezado M
    Hum Pathol; 2007 Sep; 38(9):1345-50. PubMed ID: 17509660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.
    Díaz de Ståhl T; Hansson CM; de Bustos C; Mantripragada KK; Piotrowski A; Benetkiewicz M; Jarbo C; Wiklund L; Mathiesen T; Nyberg G; Collins VP; Evans DG; Ichimura K; Dumanski JP
    Hum Genet; 2005 Oct; 118(1):35-44. PubMed ID: 16078050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced apoptosis rates in human schwannomas.
    Utermark T; Kaempchen K; Antoniadis G; Hanemann CO
    Brain Pathol; 2005 Jan; 15(1):17-22. PubMed ID: 15779232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins.
    Utermark T; Kaempchen K; Hanemann CO
    Brain Pathol; 2003 Jul; 13(3):352-63. PubMed ID: 12946024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
    Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
    Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
    Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurofibromatoses. Part 2: NF2 and schwannomatosis.
    Lu-Emerson C; Plotkin SR
    Rev Neurol Dis; 2009; 6(3):E81-6. PubMed ID: 19898272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of neurofibromatosis 2 and related tumors (acoustic neuroma and meningioma).
    Fontaine B; Rouleau GA; Seizinger BR; Menon AG; Jewell AF; Martuza RL; Gusella JF
    Ann N Y Acad Sci; 1991; 615():338-43. PubMed ID: 2039155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of chromosome 22 deletions in schwannomas.
    Bijlsma EK; Brouwer-Mladin R; Bosch DA; Westerveld A; Hulsebos TJ
    Genes Chromosomes Cancer; 1992 Oct; 5(3):201-5. PubMed ID: 1384671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
    Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of mutations in the SCH gene in schwannomas.
    Bijlsma EK; Merel P; Bosch DA; Westerveld A; Delattre O; Thomas G; Hulsebos TJ
    Genes Chromosomes Cancer; 1994 Sep; 11(1):7-14. PubMed ID: 7529050
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.